In silico Design and Analysis of Engineered Proteins Containing Multi-Epitope and Immunodominant Domains Derived From Rickettsia prowazekii Antigens
Massrehaw Assnakew Abebe, Desye Melese Sisay, Abebaw Fekadu, Abrham Tesfaye Bika, Alemu Tekewe Mogus, Tesfaye Sisay Tessema · 2026
Read In silico Design and Analysis of Engineered Proteins Containing Multi-Epitope and Immunodominant Domains Derived From Rickettsia prowazekii Antigens by Massrehaw Assnakew Abebe, Desye Melese Sisay, Abebaw Fekadu, Abrham Tesfaye Bika, Alemu Tekewe Mogus, Tesfaye Sisay Tessema (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13276219.txt.
Description
Massrehaw Assnakew Abebe and co-authors report a 2026 computer-based study designing test proteins for epidemic typhus. This louse-spread disease, caused by the bacterium Rickettsia prowazekii, still threatens many poorer regions. Current blood tests for it are often insensitive or unreliable, delaying treatment.
Using gene and protein data, the team picked two bacterial surface proteins as the most promising targets. They then designed two engineered proteins on the computer. One strings together short immune-triggering fragments; the other uses larger chunks of the natural proteins. Checks suggested both designs would be stable, soluble, and strong at provoking immune recognition. They also barely resemble human proteins, which lowers false alarms. Computer docking tests indicated steady binding to an immune receptor. Lab validation still lies ahead.
Catalog record
| CREATOR | Massrehaw Assnakew Abebe, Desye Melese Sisay, Abebaw Fekadu, Abrham Tesfaye Bika, Alemu Tekewe Mogus, Tesfaye Sisay Tessema |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71923 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |